GT Biopharma (GTBP) Ending Cash Balance (2009 - 2026)
GT Biopharma (GTBP) recorded Ending Cash Balance of $5.05 million in Q2 2026, down 5.0% from $5.32 million a year earlier and down 44.0% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, GT Biopharma reported Ending Cash Balance of $6.91 million, up 70.7% from FY2024.
- Annual Ending Cash Balance has a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
- Across earlier years, Ending Cash Balance came in at $4.04 million in FY2024 (+274.8%), $1.08 million in FY2023 (-81.0%), $5.67 million in FY2022 (-36.8%) and $8.97 million in FY2021 (+69.3%).
- Quarterly Ending Cash Balance has ranged from $1.08 million in Q4 2023 to $9.68 million in Q3 2021 over the past five years.
- On a year-over-year basis, Ending Cash Balance rose in five of the last eight quarters, with growth averaging 84.6%.
- Peak year-over-year performance for Ending Cash Balance in the last five years was growth of 274.8% in Q4 2024, against a decline of 86.4% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $9.02 million (Q1 2026), $6.91 million (Q4 2025) and $2.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.88 Bn |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | 5.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.05 Mn |
| Mar 31, 2026 | 9.02 Mn |
| Dec 31, 2025 | 6.91 Mn |
| Sep 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 6.51 Mn |
| Jun 30, 2024 | 9.25 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 2.65 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 5.67 Mn |
| Sep 30, 2022 | 2.47 Mn |
| Jun 30, 2022 | 5.36 Mn |
| Mar 31, 2022 | 7.29 Mn |
| Dec 31, 2021 | 8.97 Mn |
| Sep 30, 2021 | 9.68 Mn |
API Access
GT Biopharma Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();